Folate decorated magnetite nanoparticles: Synthesis and targeted therapy against ovarian cancer

Cell Biology International

Volumn 38, Issue 2, 2014, Pages 154-163

  Fazilati, Mohammad ^a  

^a PAYAME NOOR UNIVERSITY   (Iran)

Author keywords

Drug delivery; Encapsulation efficiency; Folic acid; Magnetic nanoparticles; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; DRUG CARRIER; FOLIC ACID; MAGNETITE NANOPARTICLE;

APOPTOSIS; CHEMISTRY; DRUG EFFECTS; FEMALE; HUMAN; OVARIAN NEOPLASMS; OVARY; PATHOLOGY; SYNTHESIS; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; FEMALE; FOLIC ACID; HUMANS; MAGNETITE NANOPARTICLES; OVARIAN NEOPLASMS; OVARY;

EID: 84895903303     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10167     Document Type: Article

References (27)

1. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-6.
2. Artursson P, Lindmark T, Davis SS, Illum L (2004) Effect of FA on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 11: 1358-61.
3. Chandra S, Mehta S, Nigam S, Bahadur D (2010) Dendritic magnetite nanocarriers for drug delivery applications. New J Chem 34: 648-55.
4. Cornell RM, Schwertmann U (2003) The iron oxides. Weinheim, Germany: Wiley-VCH.
5. Fernández-Urrusuno R, Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ (1999) Enhancement of nasal absorption of insulin using FA nanoparticles. Pharm Res 16: 1576-81.
6. Fonseca C, Simões S, Gaspar R (2002) Paclitaxel-loaded PLGA nanoparticles:preparation, physicochemical characterization and in itro anti-tumoral activity. J Control Release 83: 273-86.
7. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomater 26: 3995-4021.
8. 2 gas. Physica E 42: 1824-9.
9. Kirkin V, Joos S, Zornig M (2004) The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644: 229-49.
10. Ling X, Bernacki RJ, Brattain MG, Li FZ (2004) Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol mediated G2/M arrest. J Biol Chem 279: 15196-203.
11. Low PS, Kularatne SA (2009) Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol 13: 256-62.
12. Low PS, Henne WA, Doorneweerd DD (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 41: 120-9.
13. Mammen M, Choi SK, Whitesides GM (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 37: 2754-94.
14. 4 nanoparticles for controlled delivery of methotrexate. Res Pharm Sci 8: 25-33.
15. 2 matrix. Langmuir 18: 4972-9. http://pubs.acs.org/doi/abs/10.1021/la020037s
16. Müller B, Kreuter J (1999) Enhanced transport of nanoparticle associated drugs through natural and artificial membranes-a general phenomenon? Int J Pharm 178: 23-32.
17. Nayak S, Lee S, Chmielewski J, Lyon LA (2004) Folate-mediated cell targeting and cytotoxicity using thermoresponsive microgels. J Am Chem Soc 126: 10258-9.
18. Pandey MK, Sung B, Ahn KS (2007) Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kB signaling pathway. Blood 110: 3517-25.
19. Perez JM, Simeone FJ, Saechi Y, Josephson L, Weissleder R (2003) Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral Particles in biological media. J Am Chem Soc 125: 10192-3.
20. Qi LF, Xu ZR, Jiang X (2004) Preparation and antibacterial activity of FA nanoparticles. Carbohydr Res 339: 2693-700.
21. Sahoo Y, Pizem H, Fried T, Golodnitsky D, Burstein L, Sukenik SN, Markovich G (2001) Alkyl phosphonate/phosphate coating on magnetite nanoparticles:a comparison with fatty acids. Langmuir 17: 7907-11.
22. Saifuddin N, Dinara S (2012) Immobilization of Saccharomyces cerevisiae onto cross-linked FA coated with magnetic nanoparticles for adsorption of Uranium (VI) ions. Adv Nat Appl Sci 6: 249-67.
23. Schwertmann U, Cornell RM (2007) Iron oxides in the laboratory: preparation and characterization. 2nd ed. Germany: Wiley-VCH Verlag GmbH; p. 5-18.
24. Wang L, Zhang GM, Feng ZH (2003) Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line. Acta Pharmacol Sin 24: 1235-40.
25. Wang TT, Wei J, Qian XP, Ding YT, Yu LX, Liu BR (2008) Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells. Cancer Lett 262: 214-22.
26. Xia W, Low PS (2010) Folate-targeted therapies for cancer. J Med Chem 53: 6811-24.
27. Xu Y, Du Y (2003) Effect of molecular structure of FA on protein delivery properties of FA nanoparticles. Int J Pharm 250: 215-26.